Bioglan's shares plunge on wider 1st-half loss
Article Abstract:
Bioglan Pharma PLC saw its share value drop 85% after the firm posted a higher loss for the 2001 first-half. Bioglan posted a 35.72 million pounds pretax loss for the period, compared to 746,000 pounds during the same 2000 period.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Acambis lands contract with U.S. government
Article Abstract:
Acambis PLC has received a contract from the U.S. government to make vaccines for a possible biological attack by terrorists. The contract is valued at $343 million (372.2 million euros).
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Smith & Nephew ends battle for Centerpulse
Article Abstract:
Smith and Nephew PLC have withdrawn from the acquisition bidding for Centerpulse AG. Smith and Nephew could not outbid Zimmer Inc. for Centerpulse.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Olivetti, Mannesmann are mum on suit. Seat board extends its offer for Eniro to at least June 27. Cecchi Gori to buy rights to MTV in Italy via Beta
- Abstracts: SkyePharma's loss widened in first half. Oxford loss widened in half. Shire's earnings rise 66%, topping estimates
- Abstracts: UK's Sun Life posts strong sales for the first half. Friends Provident posts results for first half. Britannic to cut 2,000 jobs amid tough industry climate
- Abstracts: Verbund's earnings improve. RWE's net rose 22% in 1st quarter, reflecting resilience
- Abstracts: TF1's net declines 4.3% on advertising slump. Ingenico halves group net